Analgesics in Venezuela
| Product Code | EUR00691 |
| Publication Date | May 2011 |
| Publisher | Euromonitor |
| Product Type | Report |
| Pages | 28 |
| ISBN Number | not applicable |
Analgesics in Venezuela
Acetaminophen remains the most popular active ingredient in analgesics, largely due to its "safe for dengue" nature. Dengue fever is a disease transmitted by a type of mosquito (Aedes Aegypti) whose incidence increased over the review period in Venezuela. Some varieties of dengue fever may cause death if not treated quickly, so people prefer to avoid products that may worsen the problem, as some of the symptoms, especially in the early stages, are similar to those of a virus or infection.
Euromonitor International's Analgesics in Venezuela report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2006-2010, allowing you to identify the sectors driving growth. Forecasts to 2015 illustrate how the market is set to change.
Product coverage: Acne Treatments, Allergy Eye Care, Antihistamines/Allergy Remedies (Systemic), Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Child-Specific Cough, Cold and Allergy Remedies, Child-Specific Digestive Remedies, Child-Specific Medicated Skin Care, Cold Sore Treatments, Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies, Cough Remedies, Decongestants, Diarrhoeal Remedies, First Aid Kits, Gauze, Tape and Other Wound Care, Haemorrhoid Treatments, Hair Loss Treatments, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Medicated Confectionery, Medicated Shampoos, Motion Sickness Remedies, Nappy (Diaper) Rash Treatments, NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT, Pharyngeal Preparations, Standard Eye Care, Sticking Plasters/Adhesive Bandages, Systemic Analgesics, Topical Allergy Remedies/Antihistamines, Topical Analgesics/Anaesthetic, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Analgesics market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market's major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Contents
- Analgesics in Venezuela
- Euromonitor International
- May 2011
- List of Contents and Headlines
- Trends
- Switches
- Competitive Landscape
- Prospects
- Category Data
- Konsuma De Venezuela SA in Consumer Health (venezuela)
- Strategic Direction
- Key Facts
- Summary 1 Konsuma de Venezuela SA: Key Facts
- Company Background
- Production
- Competitive Positioning
- Summary 2 Konsuma de Venezuela SA: Competitive Position 2010
- Laboratorios Elmor SA in Consumer Health (venezuela)
- Strategic Direction
- Key Facts
- Summary 3 Laboratorios Elmor SA: Key Facts
- Company Background
- Production
- Competitive Positioning
- Summary 4 Laboratorios Elmor SA: Competitive Position 2010
- Laboratorios Genven SA in Consumer Health (venezuela)
- Strategic Direction
- Key Facts
- Summary 5 Laboratorios Genven SA: Key Facts
- Company Background
- Production
- Competitive Positioning
- Summary 6 Laboratorios Genven SA: Competitive Position 2010
- Vargas Ca in Consumer Health (venezuela)
- Strategic Direction
- Key Facts
- Summary 7 Vargas CA: Key Facts
- Company Background
- Production
- Competitive Positioning
- Summary 8 Vargas CA: Competitive Position 2010
- Executive Summary
- Reduced Consumption and Adverse Business Environment Limit Value Growth in 2010
- Numerous Expropriations Increase Business Risks
- Multinationals Dominate Most Categories
- Health and Beauty Retailers Continue To Gain Share
- Low Value Growth for Forecast Period Due To Regulatory Environment
- Key Trends and Developments
- Legal Framework Becomes Highly Challenging for Private Firms
- Electricity Crisis Limits Operation of Firms, Imposes Higher Costs
- Consumption Drops in Context of Economic Difficulties
- Firms Focus Social Programmes on Relevant Health Problems
- Market Indicators
- Market Data
- OTC Registration and Classification
- Vitamins and Dietary Supplements' Registration and Classification
- Self-medication/self-care and Preventative Medicine
- Switches
- Definitions
- Summary 9 Research Sources
- List of Tables
- Table 1 Sales of Analgesics by Category: Value 2005-2010
- Table 2 Sales of Analgesics by Category: % Value Growth 2005-2010
- Table 3 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
- Table 4 Analgesics Company Shares by Value 2006-2010
- Table 5 Analgesics Brand Shares by Value 2007-2010
- Table 6 Forecast Sales of Analgesics by Category: Value 2010-2015
- Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015
- Table 8 Consumer Expenditure on Health Goods and Medical Services 2005-2010
- Table 9 Life Expectancy at Birth 2005-2010
- Table 10 Sales of Consumer Health by Category: Value 2005-2010
- Table 11 Sales of Consumer Health by Category: % Value Growth 2005-2010
- Table 12 Consumer Health Company Shares by Value 2006-2010
- Table 13 Consumer Health Brand Shares by Value 2007-2010
- Table 14 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
- Table 15 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
- Table 16 Forecast Sales of Consumer Health by Category: Value 2010-2015
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015